Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-012344
Filing Date
2025-03-12
Accepted
2025-03-12 16:11:47
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741810301.html 4  
1 FORM 4 wk-form4_1741810301.xml 4 4101
  Complete submission text file 0001628280-25-012344.txt   5499
Mailing Address 41 MOORES ROAD FRAZER PA 19355
Business Address
BUCHI J KEVIN (Reporting) CIK: 0001209726 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 25731849

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)